Zhiai Xu

机构：East China Normal University · ORCID：0000-0002-4391-2507

发表论文 159 篇 · 总被引 6867 次 · h-index 48

代表论文

• Self‐Oxygenating PROTAC Microneedle for Spatiotemporally‐Confined Protein Degradation and Enhanced Glioblastoma Therapy (2025 · Advanced Materials · 被引 43)
• Tumor-specific delivery of clickable inhibitor for PD-L1 degradation and mitigating resistance of radioimmunotherapy (2024 · Science Advances · 被引 34)
• Engineering of Sono-Activatable Immunogels for Immunometabolism Disorder Normalization Therapy of Breast Cancer (2025 · Journal of the American Chemical Society · 被引 29)
• Architecting Covalent Organic Frameworks across Dimensions for Efficient H 2 O 2 Photoproduction (2025 · ACS Catalysis · 被引 22)
• Engineering STING Nanoadjuvants for spatiotemporally-tailored innate immunity stimulation and cancer vaccination therapy (2025 · Nature Communications · 被引 17)
• De Novo Design of Structure‐Tunable Multivalent Targeting Chimeras for Tumor‐Targeted PD‐L1 Degradation and Potentiated Cancer Immunotherapy (2025 · Angewandte Chemie International Edition · 被引 13)